Investor · Arlington, MA

Marc R. Lippman

Open Marc in the network graph →

Filings

11

SEC Form D

Connections

80

co-filers

Capital

$2.7M

across filings

Active

Jul 2020

to Jun 2023

Most-connected co-filers (80)

Marc Lippman · Plantation, FL5 shared Jeffrey J. Holdsberg · LOS ANGELES, CA4 shared Francis J. Greenburger · New York, NY4 shared General Partner of the General Partner 83North FXV Manager, Ltd · Herzliya, L32 shared Michael Dreyer · San Francisco, CA2 shared Patrick Faith · San Francisco, CA2 shared Matthew Quinlan · San Francisco, CA2 shared Mark Maughan · Salt Lake City, X12 shared James B. Upchurch · Los Angeles, CA2 shared Travis Olsen · Salt Lake City, X12 shared Robert J. Kantor · New York, NY2 shared Robert Jesudason · San Francisco, CA2 shared Reginald S. Van Lee · San Francisco, CA2 shared Scott Edington · San Francisco, CA2 shared Mike Nixon · Salt Lake City, UT2 shared Stan Ricks · Salt Lake City, UT2 shared David Wilkins · Columbia Falls, MT2 shared Michael Brooks · New York, NY2 shared Ryan Baughman · Salt Lake City, UT2 shared Ian R. Silverman · Arlington, MA2 shared Jedd R. Levine · Arlington, MA2 shared Kollol R. Pal · Arlington, MA2 shared Mark D. Coe · Chicago, IL2 shared Craig Romney · Salt Lake City, X12 shared

Recent filings (11)

Radiance Biopharma, Inc.Feb 2024 · 3 co-filers$30.0M Alphageneron Pharmaceuticals, Inc.Aug 2023 · 12 co-filers$250K Revere Pharmaceuticals Inc.Jun 2023 · 11 co-filers$3.6M Revere Pharmaceuticals Inc.Sep 2021 · 11 co-filers$2.0M Sundance Bay MHC Impact, LLCSep 2020 · 20 co-filers$25.0M Deep Labs, Inc.Sep 2020 · 20 co-filers$850K Deep Labs, Inc.Sep 2020 · 20 co-filers$17.5M Sundance Bay MHC Impact, LLCJul 2020 · 20 co-filers$20.0M SportsGrid, Inc.Jan 2020 · 7 co-filers$9.1M Oncology Analytics, Inc.Jan 2016 · 19 co-filers$7.5M Ascenta Therapeutics, Inc.Feb 2010 · 10 co-filers$15.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Marc in the interactive graph →